|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: C COR NET CORP, 10-Q, EX-3.1, 2000-11-06 |
Next: INTERFERON SCIENCES INC, S-1/A, S-1, 2000-11-06 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-29-2001
<PERIOD-END> SEP-29-2000
<CASH> 94,669
<SECURITIES> 48,034
<RECEIVABLES> 56,880
<ALLOWANCES> 1,700
<INVENTORY> 29,385
<CURRENT-ASSETS> 236,457
<PP&E> 73,798
<DEPRECIATION> 47,269
<TOTAL-ASSETS> 275,680
<CURRENT-LIABILITIES> 43,873
<BONDS> 0
0
0
<COMMON> 1,763
<OTHER-SE> 226,397
<TOTAL-LIABILITY-AND-EQUITY> 275,680
<SALES> 78,335
<TOTAL-REVENUES> 78,335
<CGS> 57,063
<TOTAL-COSTS> 13,287
<OTHER-EXPENSES> (1,776)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 13
<INCOME-PRETAX> 9,748
<INCOME-TAX> 3,934
<INCOME-CONTINUING> 5,814
<DISCONTINUED> 1
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,815
<EPS-BASIC> 0.17
<EPS-DILUTED> 0.16
</TABLE>
|
|